Business Context and Reporting Period
This Form 8-K filing by Pavmed Inc. covers events occurring on June 8, 2018. The company is an emerging growth corporation incorporated in Delaware. The report details the amendment of a warrant agreement and the status of an equity subscription rights offering.
Key Financial Metrics
The filing text does not provide specific values for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses on corporate governance and capital structure events rather than periodic financial performance results.
Material Changes and Events
- Amendment of Series Z Warrant Agreement: The Company amended and restated its Series Z Warrant Agreement with Continental Stock Transfer & Trust Company. Key changes include:
- Provision for electronic delivery of warrant subscription forms.
- Issuance of warrant certificates via DTCC's DWAC system.
- Implementation of monetary penalties for delays in warrant issuance or delivery.
- Protective provisions for holders regarding share ownership percentage thresholds.
- Additional protections for holders in the event of "Fundamental Transactions" (e.g., mergers, consolidations).
- Equity Subscription Rights Offering: The Company announced the expiration and anticipated closing of its equity subscription rights offering.
Guidance, Outlook, and Risks
The filing does not contain forward-looking financial guidance, management commentary on future performance, or a discussion of general business risks. The primary contingency noted is the potential for monetary penalties if the Company fails to issue or deliver warrants on time.
Investor Verification Checklist
- Verify the full terms of the Amended and Restated Series Z Warrant Agreement (Exhibit 10.1) to understand specific penalty structures and fundamental transaction protections.
- Confirm the final closing details and capital raised from the equity subscription rights offering referenced in the press release (Exhibit 99.1).
- Review the impact of the new electronic delivery and DWAC system provisions on warrant holder logistics.